Article info
Basic and translational research
Extended report
Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase
- Correspondence to Dr Karl J Lackner, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Langenbeckstrasse 1, D-55131 Mainz, Germany; karl.lackner{at}unimedizin-mainz.de
Citation
Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase
Publication history
- Received June 3, 2016
- Revised September 28, 2016
- Accepted November 5, 2016
- First published November 30, 2016.
Online issue publication
April 06, 2017
Article Versions
- Previous version (30 November 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/